EUDA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
EUDA Health Holdings Ltd is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock is currently in a bearish trend, with significant regular market decline (-15.19%) and oversold RSI levels. Analysts have lowered the price target significantly, and there are no positive catalysts, recent news, or favorable trading signals to support a buy decision. Additionally, the lack of financial data and valuation metrics further weakens the investment case.
The stock is in a bearish trend with SMA_200 > SMA_20 > SMA_5, indicating downward momentum. RSI_6 is at 13.115, signaling oversold conditions. MACD is slightly positive but contracting. Key support is at 0.388, and resistance is at 0.569. The stock has a 100% chance to increase by only 0.13% in the next day and slightly higher percentages in the next week and month, which are not compelling for long-term investment.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
Analysts have significantly lowered the price target from $6 to $2.75 due to reduced revenue estimates and dilutive effects from share issuance. The stock has experienced a sharp regular market decline (-15.19%) and is trading below key moving averages.
No financial data available for analysis. The latest quarter's financial performance could not be assessed due to missing data.
Greenridge analyst William Gregozeski maintains a Buy rating but significantly lowered the price target to $2.75 from $6 due to reduced revenue estimates and the dilutive effect of recent share issuance. This downgrade reflects a less optimistic outlook for the company.
